Journal article icon

Journal article

Minimum information about T regulatory cells: A step toward reproducibility and standardization

Abstract:

Cellular therapies with CD4+ T regulatory cells (Tregs) hold promise of efficacious treatment for the variety of autoimmune and allergic diseases as well as posttransplant complications. Nevertheless, current manufacturing of Tregs as a cellular medicinal product varies between different laboratories, which in turn hampers precise comparisons of the results between the studies performed. While the number of clinical trials testing Tregs is already substantial, it seems to be crucial to provid...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.3389/fimmu.2017.01844

Authors


Expand authors...
European Collaboration in Science and Technology More from this funder
Expand funders...
Publisher:
Frontiers Media Publisher's website
Journal:
Frontiers in immunology Journal website
Volume:
8
Issue:
JAN
Pages:
1844
Publication date:
2018-01-15
Acceptance date:
2017-12-06
DOI:
EISSN:
1664-3224
ISSN:
1664-3224
Pmid:
29379498
Source identifiers:
821877
Language:
English
Keywords:
Pubs id:
pubs:821877
UUID:
uuid:77d6e1ab-d5d8-4e0c-ac59-ee336cb13242
Local pid:
pubs:821877
Deposit date:
2018-06-12

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP